<scp>CD33</scp>‐targeting extracellular vesicles deliver antisense oligonucleotides against <scp>FLT3‐ITD</scp> and <scp>miR</scp>‐125b for specific treatment of acute myeloid leukaemia - Concepedia

Concepedia

Publication | Open Access

<scp>CD33</scp>‐targeting extracellular vesicles deliver antisense oligonucleotides against <scp>FLT3‐ITD</scp> and <scp>miR</scp>‐125b for specific treatment of acute myeloid leukaemia

DOI Full Paper Access

31

Citations

22

References

2022

Year

Huan Chen, Migara Kavishka Jayasinghe, Eric Yeo, Zhiyuan Wu, Marco Pirisinu, Waqas Muhammad Usman, Thach Tuan Pham, Kah Wai Lim, Nhan van Tran, Anskar Y.H. Leung,

Cell Proliferation

Abstract

Targeted RBCEVs represent an innovative, efficient, and versatile delivery platform for therapeutic ASOs and can expedite the clinical translation of oligonucleotide drugs for AML treatments by overcoming current obstacles in oligonucleotide delivery.

References

	Year	Citations

Page 1